• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Drug Products
  • All Drug Products

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • collapse An Open Label Prostate Cancer Study in Japanese Patients
  • collapse A Pharmacoepidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy capturing over-use and under-use via the General Practice Research Database.
  • collapse Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Postmenopausal Women With Advanced Breast Cancer
  • collapse A randomised single centre phase I study to investigate the safety, tolerability and pharmacokinetics of oral multiple ascending daily doses of AZD1236 tablet by a single-blind, placebo-controlled, and single dose relative bioavailability of the oral suspension and oral tablet formulations by an open cross-over in healthy Japanese men
  • collapse A Randomised Double-blind Phase IIa Study (With Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination With Exemestane vs. Exemestane Alone in ER+ Breast Cancer Patients With FGFR1 Polysomy or Gene Amplification Who Have Progressed Following Treatment With One Prior Endocrine Therapy (Adjuvant or First-line Metastatic)
  • expand A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
    Study Id
    D2270C00001
    Disease
    solid tumour
    Drug Name
    AZD2014
    Study Name
    D2270C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • collapse A phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
  • collapse QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
  • collapse Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
  • collapse Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013